European Society for Medical Oncology | World Briefings
Subscribe to World Briefings's newsletter

News Updates

Let's join our newsletter!

Do not worry we don't spam!

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer

World

17 Sep, 2024

Jazz Pharmaceuticals Reports Encouraging 30-Month Survival Data for Zanidatamab in Gastric Cancer


Jazz Pharmaceuticals has posted fresh phase 2 data on zanidatamab that show the HER2-targeted bispecific antibody kept 59% of people...

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage

World

16 Sep, 2024

Lung Cancer Drug Shows Promise: TIGIT-Targeting Antibody + Jemperli Combo Shows Significant Tumor Shrinkage


A targeted immunotherapy being developed by the biotech iTeos Therapeutics and GSK delivered promising response rates in patients with a...

Newsletter
Subscribe to Newsletter

Stay Tuned With Updates